$-0.02 EPS Expected for Uranium Energy Corp. (UEC); Cerus (CERS) Had 4 Analysts Last Week

May 18, 2018 - By wolcottdaily

Uranium Energy Corp. (NYSEAMERICAN:UEC) Logo

Among 5 analysts covering Cerus (NASDAQ:CERS), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. Cerus had 12 analyst reports since August 11, 2015 according to SRatingsIntel. Cantor Fitzgerald maintained the shares of CERS in report on Wednesday, June 7 with “Buy” rating. Cantor Fitzgerald maintained it with “Buy” rating and $5.0 target in Monday, January 8 report. Robert W. Baird maintained Cerus Corporation (NASDAQ:CERS) on Thursday, November 30 with “Buy” rating. The rating was maintained by Robert W. Baird on Wednesday, January 24 with “Buy”. Wedbush downgraded the shares of CERS in report on Thursday, December 17 to “Neutral” rating. Zacks downgraded Cerus Corporation (NASDAQ:CERS) on Tuesday, August 11 to “Buy” rating. The stock has “Buy” rating by Cowen & Co on Thursday, October 5. The firm has “Buy” rating given on Tuesday, May 8 by Cantor Fitzgerald. The rating was maintained by BTIG Research with “Buy” on Wednesday, August 19. The stock of Cerus Corporation (NASDAQ:CERS) earned “Buy” rating by Cantor Fitzgerald on Thursday, March 8. See Cerus Corporation (NASDAQ:CERS) latest ratings:

08/05/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $7.0000 Maintain
08/03/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $6.0 Maintain
24/01/2018 Broker: Robert W. Baird Rating: Buy New Target: $6.0 Maintain
08/01/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $5.0 Maintain
30/11/2017 Broker: Robert W. Baird Rating: Buy New Target: $5.0 Maintain

Analysts expect Uranium Energy Corp. (NYSEAMERICAN:UEC) to report $-0.02 EPS on June, 8.They anticipate $0.01 EPS change or 33.33% from last quarter’s $-0.03 EPS. After having $-0.03 EPS previously, Uranium Energy Corp.’s analysts see -33.33% EPS growth. The stock increased 1.29% or $0.02 during the last trading session, reaching $1.57. About 483,849 shares traded. Uranium Energy Corp. (NYSEAMERICAN:UEC) has declined 6.67% since May 18, 2017 and is downtrending. It has underperformed by 18.22% the S&P500.

The stock increased 1.56% or $0.1 during the last trading session, reaching $6.51. About 672,483 shares traded. Cerus Corporation (NASDAQ:CERS) has risen 26.07% since May 18, 2017 and is uptrending. It has outperformed by 14.52% the S&P500.

Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company has market cap of $849.84 million. The Company’s INTERCEPT Blood System is based on its proprietary technology for controlling biological replication; and targets and inactivates blood-borne pathogens, such as viruses, bacteria, and parasites, as well as harmful white blood cells, while preserving the therapeutic properties of platelet, plasma, and red blood cell transfusion products. It currently has negative earnings. The companyÂ’s INTERCEPT Blood Systems for platelets and plasma are designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; and INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion.

Investors sentiment increased to 1.45 in 2017 Q4. Its up 0.13, from 1.32 in 2017Q3. It improved, as 6 investors sold Cerus Corporation shares while 25 reduced holdings. 14 funds opened positions while 31 raised stakes. 58.96 million shares or 2.97% more from 57.26 million shares in 2017Q3 were reported. 36,846 were reported by State Board Of Administration Of Florida Retirement. Voya Invest Ltd Liability Com invested 0% in Cerus Corporation (NASDAQ:CERS). California Public Employees Retirement holds 0% in Cerus Corporation (NASDAQ:CERS) or 118,100 shares. Northern Trust Corporation owns 1.32 million shares. Ameritas Investment Partners Inc invested in 7,927 shares. Wells Fargo & Com Mn holds 165,208 shares. Blackrock has invested 0% in Cerus Corporation (NASDAQ:CERS). 14,328 are owned by Zeke Advsr Limited Liability Company. 313,247 were accumulated by Goldman Sachs Inc. Primecap Management Ca accumulated 7.80M shares. Jpmorgan Chase & holds 0% of its portfolio in Cerus Corporation (NASDAQ:CERS) for 106,782 shares. First Midwest Bank & Trust Tru Division reported 784,416 shares stake. The New York-based State Common Retirement Fund has invested 0% in Cerus Corporation (NASDAQ:CERS). 27,500 were reported by Elm Advsr Ltd Limited Liability Company. Zurcher Kantonalbank (Zurich Cantonalbank) stated it has 0% of its portfolio in Cerus Corporation (NASDAQ:CERS).

Since March 10, 2018, it had 1 buy, and 7 selling transactions for $159,136 activity. Greenman William Mariner had sold 17,766 shares worth $87,795. $380,865 worth of Cerus Corporation (NASDAQ:CERS) was sold by Moore Carol. Menard Chrystal also sold $22,793 worth of Cerus Corporation (NASDAQ:CERS) shares. $18,328 worth of Cerus Corporation (NASDAQ:CERS) shares were sold by Benjamin Richard J. $773,199 worth of Cerus Corporation (NASDAQ:CERS) shares were bought by CORASH LAURENCE M. Shares for $23,409 were sold by Green Kevin Dennis.

More important recent Cerus Corporation (NASDAQ:CERS) news were published by: Seekingalpha.com which released: “Cerus nabs $15M government contract” on May 17, 2018, also Investingnews.com published article titled: “Cerus Announces Additional BARDA Funding to Support Development of INTERCEPT Blood System for Red Blood Cells”, Seekingalpha.com published: “Cerus’ (CERS) CEO Obi Greenman on Q1 2018 Results – Earnings Call Transcript” on May 08, 2018. More interesting news about Cerus Corporation (NASDAQ:CERS) was released by: Globenewswire.com and their article: “New Research Coverage Highlights Cerus, Health Insurance Innovations, Tetra Tech, Ferro, Dril-Quip, and MSC …” with publication date: May 15, 2018.

Since April 5, 2018, it had 0 insider buys, and 1 sale for $64,698 activity. 49,288 shares were sold by OBARA PAT, worth $64,698 on Thursday, April 5.

Investors sentiment decreased to 1.52 in 2017 Q4. Its down 0.16, from 1.68 in 2017Q3. It dived, as 9 investors sold Uranium Energy Corp. shares while 18 reduced holdings. 13 funds opened positions while 28 raised stakes. 39.76 million shares or 9.69% more from 36.24 million shares in 2017Q3 were reported. Sigma Planning reported 0.01% stake. Telemus Cap Ltd Liability Corp has invested 0% in Uranium Energy Corp. (NYSEAMERICAN:UEC). Cqs Cayman Lp holds 764,341 shares. Parallax Volatility Advisers Limited Partnership accumulated 20,706 shares or 0% of the stock. Hightower Advsr Limited Liability Corporation has 53,701 shares. Morgan Stanley stated it has 0% in Uranium Energy Corp. (NYSEAMERICAN:UEC). Mathes holds 30,700 shares or 0.02% of its portfolio. Virtu Financial Limited Liability reported 0.05% in Uranium Energy Corp. (NYSEAMERICAN:UEC). State Street, Massachusetts-based fund reported 2.06M shares. Raymond James owns 18,800 shares or 0% of their US portfolio. Tower Capital Limited Liability Co (Trc) has 6,082 shares for 0% of their portfolio. Savings Bank Of Mellon has 0% invested in Uranium Energy Corp. (NYSEAMERICAN:UEC). Zurcher Kantonalbank (Zurich Cantonalbank) owns 6,569 shares or 0% of their US portfolio. 1492 Mngmt Ltd Liability Corp holds 0.57% or 411,235 shares in its portfolio. Atlantic Tru Grp Inc Limited Com holds 0% in Uranium Energy Corp. (NYSEAMERICAN:UEC) or 500 shares.

Uranium Energy Corp. operates as a uranium mining and exploration company. The company has market cap of $250.35 million. The Company’s projects in South Texas include the Palangana ISR mine, the permitted Goliad ISR project, and the development-stage Burke Hollow ISR project; and project in Wyoming comprise the permitted Reno Creek ISR project. It currently has negative earnings. The firm also controls a pipeline of advanced-stage uranium projects in Arizona, Colorado, New Mexico, and Paraguay, as well as a high-grade titanium project in Paraguay.

Cerus Corporation (NASDAQ:CERS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts